跳至主要内容
临床试验/NL-OMON47079
NL-OMON47079撤回不适用

Transarterial embolization of non-bleeding hepatocellular adenomas: a pilot study - Transarterial embolization of non-bleeding hepatocellular adenomas

Academisch Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Hepatocellular adenoma(HCA) * 5 cm
  • - Age at least 18 years
  • - Withdrawal from oral contraceptives at least 3 months
  • - Patient fit to undergo liver resection
  • - Patient understands both the nature and requirements of the study
  • - BMI between 18-35
  • - ASA I-III
  • - Written informed consent
  • - No suspicion of HCC (normal Alpha foeto protein level)

排除标准

  • - Inability to give written informed consent
  • - Men (increased risk of malignant transformation)
  • - HCA presenting with acute bleeding
  • - History of hepatic malignancy
  • - Pregnancy
  • - Claustrophobia (MRI)

研究者

相似试验

Transarterial embolization of non-bleeding... | 临床试验